-
Something wrong with this record ?
Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values
I. Černý, J. Prášek, H. Kašpárková,
Language English Country Germany
Document type Comparative Study, Evaluation Study, Journal Article
- MeSH
- 3-Iodobenzylguanidine * MeSH
- Child MeSH
- Infant MeSH
- Humans MeSH
- Neuroblastoma diagnostic imaging pathology MeSH
- Infant, Newborn MeSH
- Positron-Emission Tomography methods MeSH
- Child, Preschool MeSH
- Radiopharmaceuticals MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Single Photon Emission Computed Tomography Computed Tomography methods MeSH
- Neoplasm Staging MeSH
- Image Enhancement methods MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Comparative Study MeSH
OBJECTIVE: The existing most common semi-quantitative systems used for neuroblastoma diagnosis include Curie and SIOPEN scores, which are based on 123I-MIBG planar scans. The purpose of our study was to find out whether a statistically significant difference exists in evaluation based on planar and SPECT/CT scans. We also compared the Curie and SIOPEN methods in terms of their use in regular practice. Patients; method: 45 patients aged 0-10 years; 213 assessments were done in total, and the Curie and SIOPEN scores were determined in each case based on planar and SPECT/CT scans. Student's T-test and the Bland-Altman plot were used for the statistical analysis. RESULTS: Both methods demonstrated a statistically significant difference (p < 0.0001) between planar and SPECT/CT evaluation. In the group of 35 patients with neuroblastoma in clinical stages 3 and 4, in 54% of the patients SPECT/CT detected a lesion that was not visible in the planar scan. In 89% of cases, the lesion was confirmed by another imaging method (CT, MRI). In the group of 10 patients in the clinical stage 1, a difference between planar and SPECT/CT scanning was found only in one patient (10%). In the whole set, 25% patients showed a pathological finding only in soft tissues. CONCLUSION: We recommend to perform semiquantitative evaluation of neuroblastoma based on SPECT/CT scans, particularly in patients in clinical stages 3 and 4. It is advisable to include soft tissues in the score assessment, as well, given that only soft tissues may be involved in up to 25.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013966
- 003
- CZ-PrNML
- 005
- 20170427102220.0
- 007
- ta
- 008
- 170413s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3413/Nukmed-0743-15-05 $2 doi
- 035 __
- $a (PubMed)27054367
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Černý, Igor $u Igor Černý, KNM FN Brno, Jihlavská 20, 62500 Brno, Czech Republic, Tel. +420/777277427, Fax +420/532233840, igicerny@gmail.com.
- 245 10
- $a Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values / $c I. Černý, J. Prášek, H. Kašpárková,
- 520 9_
- $a OBJECTIVE: The existing most common semi-quantitative systems used for neuroblastoma diagnosis include Curie and SIOPEN scores, which are based on 123I-MIBG planar scans. The purpose of our study was to find out whether a statistically significant difference exists in evaluation based on planar and SPECT/CT scans. We also compared the Curie and SIOPEN methods in terms of their use in regular practice. Patients; method: 45 patients aged 0-10 years; 213 assessments were done in total, and the Curie and SIOPEN scores were determined in each case based on planar and SPECT/CT scans. Student's T-test and the Bland-Altman plot were used for the statistical analysis. RESULTS: Both methods demonstrated a statistically significant difference (p < 0.0001) between planar and SPECT/CT evaluation. In the group of 35 patients with neuroblastoma in clinical stages 3 and 4, in 54% of the patients SPECT/CT detected a lesion that was not visible in the planar scan. In 89% of cases, the lesion was confirmed by another imaging method (CT, MRI). In the group of 10 patients in the clinical stage 1, a difference between planar and SPECT/CT scanning was found only in one patient (10%). In the whole set, 25% patients showed a pathological finding only in soft tissues. CONCLUSION: We recommend to perform semiquantitative evaluation of neuroblastoma based on SPECT/CT scans, particularly in patients in clinical stages 3 and 4. It is advisable to include soft tissues in the score assessment, as well, given that only soft tissues may be involved in up to 25.
- 650 12
- $a 3-jodobenzylguanidin $7 D019797
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vylepšení obrazu $x metody $7 D007089
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a neuroblastom $x diagnostické zobrazování $x patologie $7 D009447
- 650 _2
- $a pozitronová emisní tomografie $x metody $7 D049268
- 650 _2
- $a radiofarmaka $7 D019275
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a SPECT/CT $x metody $7 D000072098
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Prášek, Jiri
- 700 1_
- $a Kašpárková, Helena
- 773 0_
- $w MED00010324 $t Nuklearmedizin. Nuclear medicine $x 0029-5566 $g Roč. 55, č. 4 (2016), s. 151-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27054367 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170427102540 $b ABA008
- 999 __
- $a ok $b bmc $g 1200431 $s 974744
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 55 $c 4 $d 151-7 $e 20160407 $i 0029-5566 $m Nuklearmedizin $n Nuklearmedizin $x MED00010324
- LZP __
- $a Pubmed-20170413